Picture of Corcept Therapeutics Incorporated logo

CORT — Corcept Therapeutics Incorporated News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Corcept Therapeutics Q4 EPS USD 0.2

Feb 24 (Reuters) - Corcept Therapeutics Q4 net income USD 24.288 million.

Q4 revenue USD 202.125 million vs. IBES estimate USD 254.9 million

outlook FY revenue USD 900-1,000 million

Recent news on Corcept Therapeutics Incorporated

See all news